Asfar P, Schortgen F, Boisramé-Helms J, et al, for the HYPER2S Investigators and REVA research network. Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial. Lancet Respir Med 2017; 5: 180–90—In the Procedures section of this Article (published Online First on Feb 14, 2017), it should read “Because hypertonic saline solutions are not available in France, study fluids were presented as three indistinguishable 10 mL vials of concentrated sodium chloride solutions of 0·9% or 20%”.

中文翻译：

---

更正

Asfar P，Schortgen F，Boisramé-HelmsJ等人，负责HYPER2S研究人员和REVA研究网络。败血性休克（HYPERS2S）患者的高氧血症和高渗盐水：一项二乘二析因，多中心，随机，临床试验。《柳叶刀呼吸杂志》2017; 5： 180–90 —在本文的“程序”部分（在线首次发布于2017年2月14日）中，应显示“由于高渗盐溶液在法国尚不可用，因此将研究液以三个无法区分的10 mL浓缩瓶形式呈现。 0·9％或20％的氯化钠溶液”。